文献速递神经肿瘤

术中三维超声引导下弥漫性低级别胶质瘤切除术的影像学与临床结果

Intraoperative 3D ultrasound-guided resection of diffuse low-grade gliomas: radiological and clinical results.
PubMed 文献 · J Neurosurg · 2019-02-01

这项前瞻性研究纳入2008至2015年连续47例在全身麻醉下接受三维超声引导初次手术的低级别胶质瘤患者,评估影像学与临床结果。中位切除程度为93.4%,14例(30%)实现全切除,另24例(51%)残留肿瘤小于10 ml;术后1个月86%患者健康相关生活质量维持或改善。作者结论为三维超声引导下低级别胶质瘤切除术安全,多数患者生活质量得以保留,避免术中血管损伤是获得良好功能结局的关键因素。

要点

  • 47例低级别胶质瘤患者中,中位切除程度为93.4%,14例(30%)实现全切除。
  • 另24例(51%)残留肿瘤小于10 ml,残留小于10 ml者总生存显著更好(p=0.03)。
  • 术后1个月86%患者健康相关生活质量维持或改善;两例严重永久性神经功能缺损者术后弥散加权MRI均见相关缺血。

核心结论

  • 全身麻醉下三维超声引导的低级别胶质瘤切除术是安全的,多数患者健康相关生活质量得以保留。
  • 就切除程度而言,其有效性似乎与使用其他先进神经外科工具的已发表研究一致。
  • 避免术中血管损伤是获得良好功能结局的关键因素。

研究设计与样本

  • 前瞻性研究,纳入2008至2015年间接受三维超声引导初次手术的连续低级别胶质瘤患者47例。
  • 所有低级别胶质瘤按WHO 2016分类系统分类。
  • 进行术前和术后体积评估,并将体积结果与总生存和无恶性转化生存关联。
  • 评估术前和术后健康相关生活质量。

主要发现

  • 47例中20例(43%)为IDH突变,7例(14%)为IDH野生型,19例(40%)同时有IDH突变和1p/19q共缺失,1例有IDH突变且1p/19q状态不确定。
  • 中位切除程度为93.4%,14例(30%)实现全切除,另24例(51%)残留肿瘤小于10 ml。
  • 肿瘤边界更清晰(p=0.02)和加州大学旧金山分校预后评分更低(p=0.01)与残留肿瘤组织更少相关。
  • 残留肿瘤小于10 ml者总生存显著更好(p=0.03)。
  • 术后1个月86%患者健康相关生活质量维持或改善;两例严重永久性神经功能缺损者术后弥散加权MRI均见相关缺血。

临床怎么用

  • 作者认为,全身麻醉下三维超声引导的低级别胶质瘤切除术是安全的,且多数患者健康相关生活质量得以保留。
  • 作者认为,避免术中血管损伤是获得良好功能结局的关键因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Extent of resection (EOR) and residual tumor volume are linked to prognosis in low-grade glioma (LGG) and there are various methods for facilitating safe maximal resection in such patients. In this prospective study the authors assess radiological and clinical results in consecutive patients with LGG treated with 3D ultrasound (US)-guided resection under general anesthesia. METHODS: Consecutive LGGs undergoing primary surgery guided with 3D US between 2008 and 2015 were included. All LGGs were classified according to the WHO 2016 classification system. Pre- and postoperative volumetric assessments were performed, and volumetric results were linked to overall and malignant-free survival. Pre- and postoperative health-related quality of life (HRQoL) was evaluated. RESULTS: Forty-seven consecutive patients were included. Twenty LGGs (43%) were isocitrate dehydrogenase (IDH)-mutated, 7 (14%) were IDH wild-type, 19 (40%) had both IDH mutation and 1p/19q codeletion, and 1 had IDH mutation and inconclusive 1p/19q status. Median resection grade was 93.4%, with gross-total resection achieved in 14 patients (30%). An additional 24 patients (51%) had small tumor remnants < 10 ml. A more conspicuous tumor border (p = 0.02) and lower University of California San Francisco prognostic score (p = 0.01) were associated with less remnant tumor tissue, and overall survival was significantly better with remnants < 10 ml (p = 0.03). HRQoL was maintained or improved in 86% of patients at 1 month. In both cases with severe permanent deficits, relevant ischemia was present on diffusion-weighted postoperative MRI. CONCLUSIONS: Three-dimensional US-guided LGG resections under general anesthesia are safe and HRQoL is preserved in most patients. Effectiveness in terms of EOR appears to be consistent with published studies using other advanced neurosurgical tools. Avoiding intraoperative vascular injury is a key factor for achieving good functional outcome.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bø HK, Solheim O, Kvistad KA, et al. Intraoperative 3D ultrasound-guided resection of diffuse low-grade gliomas: radiological and clinical results. J Neurosurg. 2019. PMID: 30717057. doi:10.3171/2018.10.JNS181290

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。